Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Theranostics|January 2, 2025
Development of dual aptamers-functionalized c-MET PROTAC degraders for targeted therapy of osteosarcomaXuekun Fu, Jie Huang, Xinxin Chen, et al.
Frontiers in Cell and Developmental Biology|October 5, 2020
Disorders of Calcium and Phosphorus Metabolism and the Proteomics/Metabolomics-Based ResearchMeiheng Sun, Xiaoqiu Wu, Yuanyuan Yu, et al.
Expert Reviews in Molecular Medicine|June 5, 2025
Unveiling the Therapeutic Potential: Targeting Fibroblast-like Synoviocytes in Rheumatoid ArthritisSiran Yue, Junyu Fan, Duoli Xie, et al.
Journal of Hematology & Oncology|October 30, 2025
PSMA-targeted CAR-macrophages drive glycolytic reprogramming for enhanced prostate cancer immunotherapyYangli Xu, Duoli Xie, Chunhao Cao, et al.
The American Journal of Chinese Medicine|August 21, 2023
Effectiveness of Chinese Herbal Medicine in Patients with COVID-19 During the Omicron Wave in Hong Kong: A Retrospective Case-Controlled StudyJialing Zhang, Jingyuan Luo, Hiu To Tang, et al.
Journal of Medicinal Chemistry|October 22, 2024
Design of Murine Double Minute 2 Proteolysis Targeting Chimera Degraders with a Built-In Tumor-Targeting AbilityZhuqian Wang, Siran Yue, Xinxin Chen, et al.
Journal of the American Chemical Society|December 30, 2024
Discovery of a Natural Ent-Kaurene Diterpenoid Oridonin as an E3 Ligase Recruiter for PROTACsJie Huang, Xuekun Fu, Fang Qiu, et al.
Annals of the Rheumatic Diseases|September 5, 2024
Generation of cytotoxic aptamers specifically targeting fibroblast-like synoviocytes by CSCT-SELEX for treatment of rheumatoid arthritisFang Qiu, Duoli Xie, Hongzhen Chen, et al.
Pageof 3